Frankfurt, Germany

Jens Opitz

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,307 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Introduction

Jens Opitz, based in Frankfurt-am-Main, DE, is a distinguished inventor known for his innovative contributions to medical science. With a focus on utilizing hemoglobin derivatives, he has developed a patent that aims to improve methods for determining plasma and blood volume, showcasing his commitment to enhancing healthcare technologies.

Latest Patents

Jens Opitz holds one significant patent: "Use of hemoglobin derivatives for determining plasma and/or blood volume." This invention represents a breakthrough in medical diagnostics, providing more accurate and efficient methods for assessing blood volume, which is crucial in various clinical settings.

Career Highlights

Throughout his career, Jens Opitz has demonstrated a strong dedication to research and innovation in the medical field. His expertise in hemoglobin derivatives has positioned him as a noteworthy inventor, committed to leveraging technology for the betterment of health assessments.

Collaborations

In his professional journey, Jens has collaborated with seasoned experts such as Frank Bepperling and Wolfram Eichner. These partnerships highlight the importance of teamwork in advancing research and developing cutting-edge inventions that cater to healthcare needs.

Conclusion

Jens Opitz stands out as a prominent inventor contributing to the medical field through his innovative approaches and collaborative spirit. His patent on hemoglobin derivatives exemplifies his dedication to improving blood volume assessment, reinforcing the vital role of inventors in transforming healthcare landscapes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…